Polysaccharide of Boschniakia rossica induces apoptosis on laryngeal carcinoma Hep2 cells

Gene. 2014 Feb 15;536(1):203-6. doi: 10.1016/j.gene.2013.11.090. Epub 2013 Dec 12.

Abstract

The aim of this study was to explore the anti-tumor potential of a polysaccharide isolated from Boschniakia rossica (BRP) in Hep2 human larynx squamous carcinoma cells. High performance size-exclusion chromatography analysis showed that BRP was a homogeneous polysaccharide and had a molecular weight of 22 kDa. Total carbohydrate content in BRP was determined to be 96.9%, without the presence of protein and nucleic acid. BRP suppressed the proliferation of Hep2 cells in a time- and dose-dependent manner. Cell cycle analysis revealed that exposure to BRP (200 μg/ml) caused a G0/G1 cell cycle arrest in Hep2 cells. Moreover, treatment with BRP at 100-400 μg/ml for 24h induced a significant apoptosis Hep2 cells compared to untreated control cells, as determined by flow cytometry with annexin-V/propidium iodide double staining. Additionally, BRP treatment promoted the cleavage of pro-caspase-3, pro-caspase-8, and pro-caspase-9, coupled with increased expression of death receptor DR5 and Bax and reduced expression of Bcl-2. Taken together, our data demonstrate that BRP shows potent anti-tumor activity in human larynx squamous carcinoma, largely through induction of G0/G1 cell cycle arrest and apoptosis. Activation of both mitochondria-mediated and death receptor-mediated apoptosis pathways is involved in the cytotoxicity of BRP.

Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Apoptosis; B. rossica; BRP; BSA; Boschniakia rossica; Cell cycle arrest; Chemotherapy; ConA; DEAE; DMSO; FCS; FITC; HPGPC; Hep2; MTT; OVA; Polysaccharide; SCC; TBS; TCMs; Tris buffered solution; boschniakia rossica; bovine serum albumin; concanavalin A, LPS, lipopolysaccharide; diethylaminoethyl; dimethyl sulfoxide; fetal calf serum; fluorescein isothiocyanate; high performance size-exclusion chromatography; ovalbumin; squamous cell carcinoma; traditional Chinese medicines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology*
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Humans
  • Laryngeal Neoplasms / drug therapy
  • Laryngeal Neoplasms / pathology*
  • Orobanchaceae / chemistry*
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Polysaccharides / pharmacology*
  • Polysaccharides / therapeutic use

Substances

  • Plant Extracts
  • Polysaccharides